Your browser doesn't support javascript.
loading
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.
Sheldon, Helen; Bridges, Esther; Silva, Ildefonso; Masiero, Massimo; Favara, David M; Wang, Dian; Leek, Russell; Snell, Cameron; Roxanis, Ioannis; Kreuzer, Mira; Gileadi, Uzi; Buffa, Francesca M; Banham, Alison; Harris, Adrian L.
Afiliação
  • Sheldon H; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford, United Kingdom.
  • Bridges E; Cancer Research UK Molecular Oncology Laboratories, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Silva I; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford, United Kingdom.
  • Masiero M; Cancer Research UK Molecular Oncology Laboratories, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Favara DM; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford, United Kingdom.
  • Wang D; Cancer Research UK Molecular Oncology Laboratories, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Leek R; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
  • Snell C; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford, United Kingdom.
  • Roxanis I; Cancer Research UK Molecular Oncology Laboratories, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Kreuzer M; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
  • Gileadi U; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
  • Buffa FM; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
  • Banham A; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
  • Harris AL; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford, United Kingdom.
Mol Cancer Res ; 19(11): 1957-1969, 2021 11.
Article em En | MEDLINE | ID: mdl-34348993
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia de Imunossupressão / Receptores Acoplados a Proteínas G Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia de Imunossupressão / Receptores Acoplados a Proteínas G Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article